Xagenic secures $1 million investment in chip-based technology for detecting disease, cancer and infection
MaRS Innovation, HTX, OICR and CCR commit over $1 million to speed commercialization of a new rapid molecular diagnostic technology.
Quick Links
Contact Us
Schwartz Reisman Innovation Campus, West Tower
108 College Street, Suite 530
Toronto, ON M5G 0C6
info@tiap.ca